The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment

Tekijä Pennock, Gregory K., Chow, Laura Q.M.
Julkaisussa Oncologist (2015)

Systemic therapy of brain metastases: non–small cell lung cancer, breast cancer, and melanoma

Tekijä Chamberlain, Marc C., Baik, Christina S., Gadi, Vijayakrishna K., Bhatia, Shailender, Chow, Laura Q.M.
Julkaisussa Neuro Oncol (2017)

Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity

Tekijä Anagnostou, Valsamo, Yarchoan, Mark, Hansen, Aaron R., Wang, Hao, Verde, Franco, Sharon, Elad, Collyar, Deborah, Chow, Laura Q.M., Forde, Patrick M.
Julkaisussa Clin Cancer Res (2017)

Immuno-oncology Clinical Trial Design: Limitations, Challenges, and Opportunities

Tekijä Baik, Christina S., Rubin, Eric H., Forde, Patrick M., Mehnert, Janice M., Collyar, Deborah, Butler, Marcus O., Dixon, Erica L., Chow, Laura Q.M.
Julkaisussa Clin Cancer Res (2017)

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study

Tekijä Nanda, Rita, Chow, Laura Q.M., Dees, E. Claire, Berger, Raanan, Gupta, Shilpa, Geva, Ravit, Pusztai, Lajos, Pathiraja, Kumudu, Aktan, Gursel, Cheng, Jonathan D., Karantza, Vassiliki, Buisseret, Laurence
Julkaisussa J Clin Oncol (2016)

A Phase I Clinical Trial of AZD1775 in Combination With Neoadjuvant Weekly Docetaxel and Cisplatin Before Definitive Therapy in Head and Neck Squamous Cell Carcinoma

Tekijä Méndez, Eduardo, Rodriguez, Cristina P., Kao, Michael C., Raju, Sharat, Diab, Ahmed, Harbison, R. Alex, Konnick, Eric Q., Mugundu, Ganesh M., Santana-Davila, Rafael, Martins, Renato, Futran, Neal D., Chow, Laura Q.M.
Julkaisussa Clin Cancer Res (2018)

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G(1) Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor...

Tekijä Spratlin, Jennifer L., Cohen, Roger B., Eadens, Matthew, Gore, Lia, Camidge, D. Ross, Diab, Sami, Leong, Stephen, O'Bryant, Cindy, Chow, Laura Q.M., Serkova, Natalie J., Meropol, Neal J., Lewis, Nancy L., Chiorean, E. Gabriela, Fox, Floyd, Youssoufian, Hagop, Rowinsky, Eric K., Eckhardt, S. Gail
Julkaistu 2010

Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non—Small-Cell Lung Cancer and Activating Epidermal Growth Factor...

Tekijä Leighl, Natasha B., Rizvi, Naiyer A., de Lima, Lopes Gilberto, Arpornwirat, Wichit, Rudin, Charles M., Chiappori, Alberto A., Ahn, Myung-Ju, Chow, Laura Q.M., Bazhenova, Lyudmila, Dechaphunkul, Arunee, Sunpaweravong, Patrapim, Eaton, Keith, Chen, Jihong, Medley, Sonja, Poondru, Srinivasu, Singh, Margaret, Steinberg, Joyce, Juergens, Rosalyn A., Gadgeel, Shirish M.
Julkaisussa Clin Lung Cancer (2016)

BM-32 CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL

Tekijä Shaw, Alice, Mehra, Ranee, Tan, Daniel S.W., Felip, Enriqueta, Chow, Laura Q.M., Ross Camidge, D., Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, Benjamin J., Wolf, Juergen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Geraldes, Margarida, Sen, Paramita, Boral, Anthony J., Yovine, Alejandro, Kim, Dong-Wan
Julkaistu 2014

Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 E...

Tekijä Chow, Laura Q.M., Haddad, Robert, Gupta, Shilpa, Mahipal, Amit, Mehra, Ranee, Tahara, Makoto, Berger, Raanan, Eder, Joseph Paul, Burtness, Barbara, Lee, Se-Hoon, Keam, Bhumsuk, Kang, Hyunseok, Muro, Kei, Weiss, Jared, Geva, Ravit, Lin, Chia-Chi, Chung, Hyun Cheol, Meister, Amy, Dolled-Filhart, Marisa, Pathiraja, Kumudu, Cheng, Jonathan D., Seiwert, Tanguy Y.
Julkaisussa J Clin Oncol (2016)

Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

Tekijä Shaw, Alice T., Kim, Dong-Wan, Mehra, Ranee, Tan, Daniel S.W., Felip, Enriqueta, Chow, Laura Q.M., Camidge, D. Ross, Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, Benjamin J., Wolf, Juergen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Lau, Yvonne Y., Goldwasser, Meredith, Boral, Anthony L., Engelman, Jeffrey A.
Julkaistu 2014

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Tekijä Brahmer, Julie R., Tykodi, Scott S., Chow, Laura Q.M., Hwu, Wen-Jen, Topalian, Suzanne L., Hwu, Patrick, Drake, Charles G., Camacho, Luis H., Kauh, John, Odunsi, Kunle, Pitot, Henry C., Hamid, Omid, Bhatia, Shailender, Martins, Renato, Eaton, Keith, Chen, Shuming, Salay, Theresa M., Alaparthy, Suresh, Grosso, Joseph F., Korman, Alan J., Parker, Susan M., Agrawal, Shruti, Goldberg, Stacie M., Pardoll, Drew M., Gupta, Ashok, Wigginton, Jon M.
Julkaistu 2012

Small Cell Lung Cancer: Clinical Practice Guidelines in Oncology

Tekijä Kalemkerian, Gregory P., Akerley, Wallace, Bogner, Paul, Borghaei, Hossein, Chow, Laura QM, Downey, Robert J., Gandhi, Leena, Ganti, Apar Kishor P., Govindan, Ramaswamy, Grecula, John C., Hayman, James, Heist, Rebecca Suk, Horn, Leora, Jahan, Thierry, Koczywas, Marianna, Loo, Billy W., Merritt, Robert E., Moran, Cesar A., Niell, Harvey B., O’Malley, Janis, Patel, Jyoti D., Ready, Neal, Rudin, Charles M., Williams, Charles C., Gregory, Kristina, Hughes, Miranda
Julkaistu 2013

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1–Selected Advanced Non–Small-Cell Lung Cancer (BIRCH)

Tekijä Peters, Solange, Gettinger, Scott, Johnson, Melissa L., Jänne, Pasi A., Garassino, Marina C., Christoph, Daniel, Toh, Chee Keong, Rizvi, Naiyer A., Chaft, Jamie E., Carcereny Costa, Enric, Patel, Jyoti D., Chow, Laura Q.M., Koczywas, Marianna, Ho, Cheryl, Früh, Martin, van den Heuvel, Michel, Rothenstein, Jeffrey, Reck, Martin, Paz-Ares, Luis, Shepherd, Frances A., Kurata, Takayasu, Li, Zhengrong, Qiu, Jiaheng, Kowanetz, Marcin, Mocci, Simonetta, Shankar, Geetha, Sandler, Alan, Felip, Enriqueta
Julkaisussa J Clin Oncol (2017)